UAE Obesity Masterclass V.2 Kicks Off Tomorrow In Dubai Under Emirati Chairwomanship
The UAE Obesity Masterclass V.2 will kick off tomorrow (Friday, September 13) with the participation of leading UAE experts, health care professionals as well as specialists from various public and private health bodies, at the Intercontinental Festival City.
Chaired by a senior Emirati official, the 2nd edition of the event is organized by Novo Nordisk, the global healthcare leader with more than 95 years of innovation and leadership in diabetes and obesity care, in collaboration with the World Obesity Federation.
The conference will bring together an elite group of doctors and specialists from the country’s public and private sector, in addition to speakers and specialists from the UAE, Canada and Denmark. The participants will hold a series of dialogues and panel discussions to identify opportunities and challenges, and highlight the latest global practices and mechanisms used in the treatment of obesity.
Dr. Fatheya Al Awadi, Chairwoman of UAE Obesity Masterclass, Head of the Endocrine Department-Dubai Hospital and President of the Emirates Diabetes Society, stressed on the significance of the obesity masterclass which acts as a platform bringing together some of the best global and local obesity experts in the medical community.”
She added: “Obesity is one of the biggest challenges facing health care systems in the world. For UAE in particular this is even more significant
considering the high prevalence of obesity.”
Dr. Ayman Hassan, Vice President and UAE General Manager at Novo Nordisk said: “We support the UAE’s efforts to reduce the prevalence of obesity in the longer-term, in line with the UAE Vision 2021 National Agenda, and the National Program to Combat Obesity. Today, obesity is one of the most chronic health problems in our society and a major cause of chronic diseases.”
“The UAE Obesity Masterclass will reinforce the company’s commitment to supporting obesity clinics, health practitioners and specialists, so as to provide a comprehensive and integrated treatment journey for patients. In the past year, we have started implementing a project to develop obesity clinics in the UAE to ensure that most of patients with obesity receive care”, he further said.
Interestingly, Novo Nordisk launched a one-year initiative to support 50 children with type 1 diabetes in the country last year. The initiative was implemented in cooperation with the Friends of Diabetes Association, one of the health-promoting organizations under the Health Education Department of the Supreme Council for Family Affairs in Sharjah and the Emirates Red Crescent (ERC).
